L&K Biomed Granted FDA Clearance for Expandable Interbody

L&K Biomed obtained FDA clearance to market PathLoc™, a next-generation height-expandable spinal implant product for the treatment of spinal diseases.

PathLoc is used in the posterior and posterolateral positions, where the procedure is most frequently performed in spinal implants.

According to L&K Biomed, the expandable interbody cage...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us